SSN 36C25626Q0942.pdf

Department of Veterans Affairs

Network Contracting Office (NCO) 16

Sources Sought Notice (SSN)

DISCLAIMER:

This Sources Sought Notice (SSN) is issued solely for informational and market research purposes and does not constitute a solicitation. This notice shall not be construed as a commitment by the Government to award a contract, nor does it obligate the Government to any acquisition action. Responses to this notice are strictly voluntary; the Government will not reimburse any costs associated with responding. Respondents should not include proprietary or restricted information. If a solicitation is issued, it will be posted on SAM.gov. It is the responsibility of the interested parties to monitor this site for additional information pertaining to this SSN.

1. Title

T-SPOT.TB Assay Testing

2. Purpose

The purpose of this SSN is to identify qualified and capable sources to assist in determining the appropriate acquisition strategy (e.g., small business set‑aside, unrestricted). Responses will support the VA’s market research for an anticipated requirement.

3. NAICS and PSC Information

Primary NAICS: 621511 – Medical Laboratories. Small Business Size Standard: $41.5M average annual receipts.

4. Required Vendor Responses

Vendors must provide complete responses to all items below to be considered responsive to this

SSN:

1. Does your laboratory perform the T‑SPOT.TB assay in‑house (not collection‑only or forwarded to another laboratory)?

1a. Provide documentation confirming in‑house performance, including current test menu, methodology, and location(s) where the assay is performed.

2. Describe your laboratory’s logistics and courier capabilities.

2a. Can your organization provide daily Monday–Friday specimen pickup from the G.V.

(Sonny) Montgomery VAMC in Jackson, MS?

2b. Confirm your ability to ensure specimen receipt and processing within the required

24–39‑hour stability window.

2c. Provide evidence of courier routes, pickup schedules, chain‑of‑custody processes, and sample viability controls.

3. Provide proof of current accreditation.

3a. Submit copies of your CLIA certificate and CAP accreditation, including certificate numbers, effective dates, and testing specialties that cover immunologic and

ELISPOT‑based assays.

4. Provide organizational information:

4a. Company name, primary laboratory location(s) where the T‑SPOT.TB assay is performed, point of contact, phone number, email, address.

4b. Business size designation (Large, SB, SDVOSB, VOSB, HUBZone, 8(a)).

4c. Provide your UEI and CAGE Code.

4d. For SDVOSB/VOSB, include SBA VetCert documentation.

5. Identify any Government contract vehicles under which your laboratory testing services are available.

5a. Include GSA Schedule, IDIQ, BPA, VA FSS, or GWAC numbers, and the relevant

SINs or laboratory service categories that apply.

6. Confirm your laboratory’s ability to meet the SOW requirements, including but not limited to:

6a. Ability to process T‑SPOT.TB specimens within the manufacturer‑specified stability window (not to exceed 32 hours from time of collection) and report final results to the VA within 72 hours of specimen submission.

6b. Daily courier pickup Monday–Friday (excluding holidays).

6c. Inclusion of VA identifiers (ICN or EDIPI) in result reports.

6d. Faxed delivery of results and compliance with VISTA/VA workflows.

6e. Ability to meet volume requirements (approximately 1,700 tests annually).

6f. Provide supporting documentation demonstrating your capability to meet all technical and operational requirements.

7. Provide cybersecurity, privacy, and information security compliance details relevant to handling VA-sensitive information.

7a. Acknowledge your ability to comply with VA information security, privacy, background investigation, and records‑management requirements outlined in the SOW.

7b. Confirm your ability to ensure encryption, secure transmission of PHI, and adherence to VA directives.

8. If your laboratory offers an accessibility resource or system used for VA reporting or result delivery, provide any applicable Section 508 Accessibility Conformance Report

(VPAT/ACR).

8a. If not applicable, state “N/A – No user‑facing software or digital platform provided to

VA under this requirement.”

9. Provide any additional information demonstrating your organization’s ability to meet all performance, regulatory, and operational requirements stated in the Statement of

Work.

5. Instructions for Responses

Questions regarding this SSN shall be submitted by 12:00 PM (CST), June 22, 2026, to

William.Shaver@va.gov. Responses must be submitted by 07:00 AM (CST), June 23, 2026, in

Microsoft Word or PDF format to the same email address. Include the subject line: “VAMC T-

SPOT.TB Assay Testing – SSN Response.”

6. Market Pricing

Vendors are encouraged to provide estimated market pricing. Pricing information provided will assist the VA in determining procurement strategy and is considered part of market research only.

7. Additional Information

Information provided will be used solely for market research and will not be released outside the

VA acquisition team. If no capable and CLIA/CAP‑accredited laboratories respond demonstrating the ability to perform the T‑SPOT.TB assay in‑house and meet all requirements of this notice, the Government will proceed with a sole‑source action to the only known qualified source.

8. Contact Information

William Shaver

William.Shaver@va.gov

9. Background - SOW

Please see the draft Statement of Work (SOW), provided as Attachment A, for additional background and technical information.

mailto:William.Shaver@va.gov